| pubmed-article:21757431 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0020202 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0242957 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0024623 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0069515 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0017428 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0008659 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0444498 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0443131 | lld:lifeskim |
| pubmed-article:21757431 | lifeskim:mentions | umls-concept:C0677862 | lld:lifeskim |
| pubmed-article:21757431 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:21757431 | pubmed:dateCreated | 2011-9-28 | lld:pubmed |
| pubmed-article:21757431 | pubmed:abstractText | Determination of HER2 protein expression by immunohistochemistry (IHC) and genomic status by fluorescent in situ hybridisation (FISH) are important in identifying a subset of high HER2-expressing gastric cancers that might respond to trastuzumab. Although FISH is considered the standard for determination of HER2 genomic status, brightfield ISH is being increasingly recognised as a viable alternative. Also, the impact of HER2 protein expression/genomic heterogeneity on the accuracy of HER2 testing has not been well studied in the context of gastric biopsy samples. | lld:pubmed |
| pubmed-article:21757431 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21757431 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21757431 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21757431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21757431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21757431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21757431 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21757431 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:21757431 | pubmed:issn | 1472-4146 | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:Salto-TellezM... | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:YanBenedictB | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:PangBrendanB | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:OngChee WeeCW | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:YauEe XuanEX | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:YongKol JiaKJ | lld:pubmed |
| pubmed-article:21757431 | pubmed:author | pubmed-author:ChooShoa... | lld:pubmed |
| pubmed-article:21757431 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21757431 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:21757431 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21757431 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21757431 | pubmed:pagination | 880-3 | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:meshHeading | pubmed-meshheading:21757431... | lld:pubmed |
| pubmed-article:21757431 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21757431 | pubmed:articleTitle | Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples. | lld:pubmed |
| pubmed-article:21757431 | pubmed:affiliation | Department of Pathology, National University Health System and National University of Singapore, Singapore. | lld:pubmed |
| pubmed-article:21757431 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21757431 | pubmed:publicationType | Comparative Study | lld:pubmed |
| entrez-gene:2064 | entrezgene:pubmed | pubmed-article:21757431 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21757431 | lld:entrezgene |
